How many patents does
Biocryst Pharmaceuticals have?
patents
440
families
46
granted
60
applications
380
US
56
EP
45
WO
39
JP
21
CN
20
KR
19
RoW
240
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Biocryst Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
| biocryst pharmaceuticals | 359 |
| biocryst pharm | 10 |
| biocryst pharmaceuticals, inc. (a … 🛈 | 4 |
| hitachi | 3 |
| biocryst pharmaceutical | 1 |
| biocryst pharmaceticals | 1 |
2009
| biocryst pharmaceuticals | 33 |
| biocryst pharm | 2 |
Biocryst Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| methods and compositions for inhibition of polymerase | 49 | 2010 |
| methods of treating hematologic cancers using pnp inhibitors such as forodesine in combi… 🛈 | 42 | 2007 |
| useful pharmaceutical salts of 7-[(3r, 4r)-3-hydroxy-4-hydroxymethyl-pyrrolidin-1-ylmeth… 🛈 | 28 | 2009 |
| intravenous antiviral treatments | 26 | 2006 |
| compositions and methods for inhibiting viral polymerase | 21 | 2012 |
| antiviral nucleoside analogs | 20 | 2007 |
| antiviral therapeutic agents | 17 | 2008 |
| human plasma kallikrein inhibitors | 16 | 2015 |
| human plasma kallikrein inhibitors | 16 | 2014 |
| substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors | 15 | 1997 |